Beerse, Belgium

Marcus Eli Brewster

USPTO Granted Patents = 2 



Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2008-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Marcus Eli Brewster

Introduction

Marcus Eli Brewster is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, holding 2 patents that showcase his innovative approach to drug formulation. His work focuses on improving the solubility and stability of pharmaceutical compounds, which is crucial for effective drug delivery.

Latest Patents

Brewster's latest patents include a novel pharmaceutical composition that comprises a basic drug compound, a surfactant, and a physiologically tolerable water-soluble acid. This invention is characterized by a specific acid or base to drug compound ratio of at least 1:1 by weight, which enhances the efficacy of the drug. Another significant patent involves solid dispersions that consist of a poorly soluble bioactive compound dispersed in a polymer matrix. This invention effectively stabilizes the dispersed compound while promoting its solubilization in an aqueous environment, addressing a common challenge in pharmaceutical formulations.

Career Highlights

Marcus Eli Brewster is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative drug formulations that can significantly impact patient care and treatment outcomes.

Collaborations

Brewster collaborates with various professionals in his field, including his coworker Jozef Peeters. These collaborations enhance the research and development process, leading to more effective pharmaceutical solutions.

Conclusion

Marcus Eli Brewster's contributions to pharmaceutical innovations demonstrate his commitment to improving drug formulations. His patents reflect a deep understanding of the complexities involved in drug development, making him a valuable asset in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…